NeuroXPF Gets COVID Warning Letter From FDA

Within days of proclaiming in social media that its CBD products could cure COVID19, the Food & Drug Administration (FDA) sent a warning letter to NeuroXPF. The letter stated, “We request that you take immediate action to cease the sale of such unapproved and unauthorized products for the mitigation, prevention, treatment, diagnosis, or cure of COVID-19.”

NeuroXPF is a cannabidiol product company founded by former NFL player Kyle Turley. The company boldly went on social media suggesting that by using its products it could help people’s immune systems in the fight against COVID19.

  • “Crush Corona . . . While scientists around the world are working 24/7 to develop a COVID-19 vaccine, it will take many more months of testing before it’s approved and available. However, there’s something you can do right now to strengthen your immune system. Take CBD . . . CBD can help keep your immune system at the stop of its game. . . . We want everyone to take CBD and take advantage of its potential to help prepare your body to fight a coronavirus infection. So, we’re making all of our products more affordable.” [from your website]
  • “Crush Corona! Your best defense against the COVID-19 blitz starts with a strong immune system. It’s what protects your body from the everyday attacks of bacteria, viruses, parasites and a host of other nasties. Learn more here:” [from March 19 posts on your social media websites and]

Even people within the cannabis community chastised Turley for making claims that most knew would make it a target of the FDA. It may even have been a big PR stunt as the founder doubled down saying he’d welcome the FDA’s enforcement. He thinks such an action would expose the government for “covering up the potential of the plant.”

FDA Response

The letter stated, “We advise you to review your websites, product labels, and other labeling and promotional materials to ensure that you are not misleadingly representing your products as safe and effective for a COVID-19-related use for which they have not been approved by FDA and that you do not make claims that misbrand the products in violation of the FD&C Act.” The company has two days to make the changes and if it doesn’t it could result in legal action, including, without limitation, seizure and injunction.


While top scientists around the globe are looking for a vaccine and top medical workers are trying numerous methods to treat the deadly virus, Turley is basing his information on anecdotal evidence. He says he has had conversations with experts in the field but does not name the experts.

Other cannabis companies have received FDA warning letters in the past and have been able to address those issues and move on. Charlotte’s Web faced such a situation and made the requested changes. It makes selling CBD more challenging since the company can hardly even describe what it does, but Charlotte’s Web has satisfied the FDA and still owns a large market share in the CBD space.

The website does not mention COVID at this time and while Turley continues to state on his Twitter feed that he continues to believe in the effectiveness of CBD for COVID, the NeuroXPF feed does not mention the virus. It focuses instead on brain injury awareness.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.